GORE SYNECOR Biomaterial
Commercial- Indications
- Hernia repair, Abdominal wall defects, Thoracic wall defects
Company intelligence / Profile preview
Synecor operates as a medical device accelerator/incubator focused on developing innovative cardiovascular and surgical devices. It has successfully spun out several companies and products, including those targeting acute heart failure and advanced biomaterials for hernia repair. The company holds over 50 patents related to cardiac surgery and anatomy. Its model involves partnering with thought leaders to develop new technologies across multiple specialties.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synecor.